Short communication · 3 Oct 2022
Rapid communicationPublished 18 Feb 2022
Controlling Hypertension: Cardiology Practices
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Albeit the world's consideration is bolted on the Covid infection 2019 (COVID-19) pandemic, it is vital for keep sight of other exceptionally hazardous circumstances which have not decreased during these times. The worldwide weight of cardiovascular infections qualifies as such a worry, and hypertension is foremost. Also, while uncontrolled hypertension, as such, has not been affirmed as a free indicator of serious intricacies or demise from COVID-19, it brings about heart and kidney infection and stroke, to a great extent preventable circumstances that increment weakness to wellbeing dangers, including COVID-19.
Subjects
Pathology & Lab MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 15 Apr 2019
Improving hypertension control via a team-based educational and refill monitoring (term) intervention, Sharjah, United Arab Emirates
Research article · 3 Apr 2018
Clinical effect of combined controlled-release nifedipine tablets-valsartan therapy on elderly patients suffering from type II diabetic nephropathy with hypertension
Conference abstract · 12 Oct 2017
SHORT PERIOD OF CALORIC RESTRICTION DECREASES GLUCOSE LEVELS AND DYSLIPIDEMIA CONTROLLING HYPERTENSION IN TYPE 2 DIABETIC MELLITUS PATIENTS.
Research article · 2012
Hypertension Prevalence, Awareness, Treatment and Control in the Urban District of Wuhan, China: Implications for Community Nursing Practice
More from this journal
The newest in Annals of Clinical and Laboratory Research.
Commentary · 8 Oct 2025
Cardiometabolic Therapies at the Crossroads of Coronary Artery Disease
Mini review · 2 Oct 2025
Characteristics and Treatment of Juvenile Myasthenia Gravis
Commentary · 9 Jul 2025
Commentary on Upadacitinib in Difficult-to-Treat Psoriatic Arthritis: Real-World Data from 134 Patients
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAnnals of Clinical and Laboratory Research
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “William Janet”

